How Will Emyria’s New Brisbane Clinic Transform Mental Health Access?
Emyria has secured a multi-year funding extension with Medibank to launch its Empax mental health programs in Brisbane, marking a key step in its national expansion. This insurer-backed initiative aims to improve access to treatment for complex conditions like treatment-resistant depression and PTSD.
- Medibank funds Empax programs for eligible patients at Brisbane’s Avive Clinic
- First insurer-backed mental health services expansion beyond Western Australia
- Brisbane clinic operations to commence in Q4 2025
- Empax model validated as scalable across multiple hospital partners
- Supports Emyria’s national growth strategy in evidence-based mental health care
National Expansion of Insurer-Backed Mental Health Care
Emyria Limited (ASX, EMD), a pioneer in evidence-based mental health treatments, has announced a significant expansion of its partnership with Medibank Private Ltd (ASX, MPL). The multi-year funding agreement now includes support for eligible Medibank customers to access Emyria’s Empax programs for Treatment-Resistant Depression (TRD) and Post-Traumatic Stress Disorder (PTSD) at a new clinic in Brisbane, operated in association with Avive Health.
This marks the first time Emyria’s insurer-backed services will be available on Australia’s east coast, extending beyond its initial operations in Western Australia. The Brisbane Empax Clinic is set to begin treating patients in the fourth quarter of 2025, following clinic fit-out and regulatory approvals.
Addressing Complex Mental Health Needs with Scalable Care
TRD and PTSD represent some of the most challenging mental health conditions, often requiring specialist, multidisciplinary care that is difficult to access or afford through public health systems. Emyria’s Empax Centres offer psychiatrist-led, psychotherapy-based programs that integrate hospital-based care with insurer funding, significantly reducing financial barriers for patients.
Each treatment program typically involves a comprehensive course of care valued between $20,000 and $30,000, underscoring the clinical depth and resource intensity involved. The partnership with Medibank not only facilitates patient access but also validates the scalability of Emyria’s data-driven care model across different hospital partners and jurisdictions.
Strategic Implications and Future Growth
Emyria’s expansion into Brisbane strengthens its position as a national leader in evidence-based mental health care. By embedding insurer-backed funding into hospital-integrated programs, the company is pioneering a replicable framework that could transform access to complex mental health treatments across Australia.
Executive Chairman Greg Hutchinson highlighted the importance of this milestone, emphasizing the company’s commitment to making world-class mental health care accessible nationwide. The collaboration with Medibank exemplifies a sustainable approach to delivering measurable, outcomes-driven care that benefits patients, clinicians, and the broader health system.
Looking ahead, Emyria plans to accelerate the rollout of Empax Centres across metropolitan and regional areas, exploring further partnerships with hospitals and insurers. This strategy aligns with growing demand for coordinated, affordable mental health services and positions Emyria as a key player in addressing Australia’s escalating mental health burden.
Bottom Line?
Emyria’s insurer-backed expansion to Brisbane signals growing momentum in scalable, accessible mental health care across Australia.
Questions in the middle?
- How quickly will patient uptake at the Brisbane clinic impact Emyria’s financials?
- Will other insurers follow Medibank’s lead in funding Empax programs nationally?
- What regulatory or operational challenges might affect the pace of Emyria’s national rollout?
